Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford.
Aser AbrhaNavika D ShuklaRachel HodanTeri LongacreShyam Sampath RaghavanColin C PritchardGeorge FisherJames FordSigurdis HaraldsdottirPublished in: JNCI cancer spectrum (2020)
Given the relatively high incidence of dMMR in GI malignancies, we recommend screening all GI malignancies. Our results suggest that although a rare occurrence, double somatic pathogenic variants may be a biologically significant pathway causing dMMR in pancreatic cancer.